Mule Regulates the Intestinal Stem Cell Niche via the Wnt Pathway and Targets EphB3 for Proteasomal and Lysosomal Degradation
Carmen Dominguez‐Brauer(University Health Network), Tak W. Mak(University Health Network), Toshiro Sato(Keio University), Johan H. van Es(Utrecht University), David M. Sabatini(Czech Academy of Sciences, Institute of Organic Chemistry and Biochemistry), Jennifer Silvester(Ontario Institute for Cancer Research), Patrick M. Brauer(University of Illinois Urbana-Champaign), Jillian Haight(University Health Network), Andrew Wakeham(Ontario Institute for Cancer Research), Satoshi Inoue(University of Leicester), Miyeko Mana(Arizona State University), Leanne Tworzyanski(Ontario Institute for Cancer Research), Hans Clevers(Hubrecht Institute for Developmental Biology and Stem Cell Research), Aaron Pollett(Mount Sinai Hospital), Andrew Elia(Ontario Institute for Cancer Research), Iok In Christine Chio(Cancer Genetics (United States)), Jérôme Fortin(Princess Margaret Cancer Centre), R. A. Cairns(University of St Andrews), Maureen A. Cox(University Health Network), Colin Reardon(University of California, Davis), Robert Nechanitzky(University Health Network), Ömer Yılmaz(Ondokuz Mayıs University), Zhenyue Hao(Princess Margaret Cancer Centre), Yi Sheng(York University), Ana Catia Ferrao Marques(Ontario Institute for Cancer Research)
Cited by 30
Related Papers
Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1
|Nature|2009|4.2k
mTOR: from growth signal integration to cancer, diabetes and ageing
|Nature Reviews Molecular Cell Biology|2010|4k
Organoid Models of Human and Mouse Ductal Pancreatic Cancer
|Cell|2014|2.2k
mTOR signaling at a glance
|Journal of Cell Science|2009|2.1k